Chen Cao
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Testing menstrual blood for human papillomavirus during cervical cancer screening in China: cross sectional population based study.
Journal: BMJ (Clinical research ed.)
Published: February 04, 2026
Proteogenomic characterization of cervical cancer identifies molecular subtypes predictive of clinical outcomes and subtype-specific targets.
Journal: The Journal of clinical investigation
Published: September 05, 2025
High-Throughput Targeted Sequencing Identifies an HPV Methylation Panel for Detecting Cervical Lesion Progression.
Journal: Journal of medical virology
Published: February 28, 2025
Correction: Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients.
Journal: European journal of medical research
Published: June 26, 2024
Risk assessment and triage strategy of cervical cancer primary screening on HPV integration status: 5-year follow-up of a prospective cohort study.
Journal: Journal of the National Cancer Center
Published: June 12, 2024
Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients.
Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients.
Journal: European journal of medical research
Published: May 29, 2023
A cross-sectional study of human papillomavirus genotype distribution and integration status in penile cancer among Chinese population.
Journal: Virology
Published: February 26, 2023
Downregulation of VPS13C promotes cisplatin resistance in cervical cancer by upregulating GSTP1.
Journal: iScience
Published: October 07, 2022
Massively parallel CRISPR off-target detection enables rapid off-target prediction model building.
Journal: Med (New York, N.Y.)
Published: July 07, 2022
Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway.
Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway.
Journal: Current cancer drug targets
Published: November 22, 2021
Last Updated: 09/26/2026